The genetic attributable risk of breast and ovarian cancer

Cancer

Volumn 77, Issue 11, 1996, Pages 2318-2324

  Claus, Elizabeth B ^a,e   Schildkraut, Joellen M ^b   Thompson, W Douglas ^c   Risch, Neil J ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN MAINE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

attributable risk; breast cancer; family history; genetic epidemiology; ovarian cancer

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGE OF ONSET; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; LIFE TABLES; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENES; OVARIAN NEOPLASMS; RISK; TRANSCRIPTION FACTORS;

EID: 0029955159     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z     Document Type: Article

References (38)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigjan S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71.
2. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
3. Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 1991;338:82-3.
4. Easton DF, Bishop DT, Ford D, Crockford GP, and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
5. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 1994; 8:387-91.
6. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 1994; 8:392-8.
7. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994;8:399-404.
8. Wooster R, Neuhausen SL, Mangion I, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265: 2088-90.
9. King MC. Late-breaking research session. American Society of Human Genetics Annual Meeting. Montreal Quebec, Canada, 1994.
10. Wingo PA, Ory HW, Layde PM, Lee NC, and the Cancer and Steroid Hormone Study Group. The evaluation of the data collection process for a multicenter, population-based case-control design. Am J Epidemiol 1988;128:206-17.
11. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 1991;48:232-42.
12. Kaplan EB, Elston RC. A subroutine package for maximum likelihood estimation (MAXLIK). Inst Stat Mimeo Ser 823. Chapel Hill: University of North Carolina, 1972.
13. Dixon WJ, (editor). BMDP statistical software. Los Angeles: Regents of the University of California, 1990.
14. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk: the Utah Population Database. JAMA 1993;270:1563-8.
15. King MC, Rowell S, Love SM. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 1993;269:1975-80.
16. Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, Manson JE, Hennekens CH, et al. Family history, age, and risk of breast cancer. JAMA 1993;270:338-43, 1548.
17. Claus EB, Risch N, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961-72.
18. Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer (First of three parts) N Engl J Med 1992;327:319-28.
19. Lynch HT, Watson P, Conway T, Fitzsimmons SL, Lynch J. Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 1988;11: 263-7.
20. Newman B, Austin MA, Lee M, King MC. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci USA 1988;85:1-5.
21. Schwartz AG, King MC, Belle SH, Satariano WA, Swanson GM. Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 1985;75:665-8.
22. Ford D, Easton DF, Bishop DT, Narod SA, and the Breast Cancer Consortium. The risks of cancer in BRCA1 mutation carriers. Am J Hum Genet 1993;53:A298.
23. Easton D, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 1995;56:265-71.
24. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risk of cancer in BRCA1-mutation carriers. Lancet 1994;343:692-5.
25. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
26. Schildkraut JM, Thompson WD. Familial ovarian cancer: a population-based case-control study. Am J Epidemiol 1988; 128:456-66.
27. Claus EB, Risch NR, Thompson WD, Carter D. Relationship between breast histopathology and family history of breast cancer. Cancer 1993;71:147-53.
28. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, et al. A collaborative study of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995;273:535-41.
29. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 1996;334:137-42.
30. Fitzgerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early onset breast cancer. N Engl J Med 1996;334:143-9.
31. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995;11:198-200.
32. Serova O, Montagna M, Torchard D, Narod SA, Tonin P, Sylla B, et al. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 1996;58:42-51.
33. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. An association between the risk of cancer and mutations in the Hras1 minisatellite locus. N Engl J Med 1993;329:517-23.
34. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
35. Swift M, Reitnauer PJ, Morrell D, Chase CL Breast and other cancers with ataxia-telangiectasia. N Engl J Med 1987;316: 1289-94.
36. King MC. Breast cancer genes: how many, where, and who are they? Nat Genet 1992;2:89-90.
37. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-2.
38. Davies K. Breaking down BRCA1 (editorial). Nat Genet 1994;8:310.